264 related articles for article (PubMed ID: 32759967)
1. Dysregulated adaptive immune response contributes to severe COVID-19.
Yu K; He J; Wu Y; Xie B; Liu X; Wei B; Zhou H; Lin B; Zuo Z; Wen W; Xu W; Zou B; Wei L; Huang X; Zhou P
Cell Res; 2020 Sep; 30(9):814-816. PubMed ID: 32759967
[No Abstract] [Full Text] [Related]
2. [Adaptive immunity against SARS-CoV-2].
Combadière B
Med Sci (Paris); 2020 Oct; 36(10):908-913. PubMed ID: 32960167
[TBL] [Abstract][Full Text] [Related]
3. HMGB1: A Possible Crucial Therapeutic Target for COVID-19?
Street ME
Horm Res Paediatr; 2020; 93(2):73-75. PubMed ID: 32375153
[No Abstract] [Full Text] [Related]
4. Convalescent donor SARS-COV-2-specific cytotoxic T lymphocyte infusion as a possible treatment option for COVID-19 patients with severe disease has not received enough attention till date.
Hanley B; Roufosse CA; Osborn M; Naresh KN
Br J Haematol; 2020 Jun; 189(6):1062-1063. PubMed ID: 32369628
[No Abstract] [Full Text] [Related]
5. Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2-Induced Cytokine Storm.
Nowill AE; de Campos-Lima PO
J Immunol; 2020 Nov; 205(10):2566-2575. PubMed ID: 32958687
[TBL] [Abstract][Full Text] [Related]
6. Not just antibodies: B cells and T cells mediate immunity to COVID-19.
Cox RJ; Brokstad KA
Nat Rev Immunol; 2020 Oct; 20(10):581-582. PubMed ID: 32839569
[TBL] [Abstract][Full Text] [Related]
7. Seeking and destroying the evils from the inside-translating cancer immunity to fight COVID-19.
Dong H
Cancer Immunol Immunother; 2020 Jun; 69(6):911-912. PubMed ID: 32347359
[No Abstract] [Full Text] [Related]
8. Optimizing Administration of CAR T-Cell Therapy During the COVID-19 Pandemic.
Bishop MR
Clin Adv Hematol Oncol; 2020 Jul; 18(7):400-403. PubMed ID: 32903251
[No Abstract] [Full Text] [Related]
9. Comprehensive mapping of immune perturbations associated with severe COVID-19.
Kuri-Cervantes L; Pampena MB; Meng W; Rosenfeld AM; Ittner CAG; Weisman AR; Agyekum RS; Mathew D; Baxter AE; Vella LA; Kuthuru O; Apostolidis SA; Bershaw L; Dougherty J; Greenplate AR; Pattekar A; Kim J; Han N; Gouma S; Weirick ME; Arevalo CP; Bolton MJ; Goodwin EC; Anderson EM; Hensley SE; Jones TK; Mangalmurti NS; Luning Prak ET; Wherry EJ; Meyer NJ; Betts MR
Sci Immunol; 2020 Jul; 5(49):. PubMed ID: 32669287
[TBL] [Abstract][Full Text] [Related]
10. The many faces of the anti-COVID immune response.
Vardhana SA; Wolchok JD
J Exp Med; 2020 Jun; 217(6):. PubMed ID: 32353870
[TBL] [Abstract][Full Text] [Related]
11. Positive outcome in a patient with coronavirus disease 2019 and common variable immunodeficiency after intravenous immunoglobulin.
Aljaberi R; Wishah K
Ann Allergy Asthma Immunol; 2020 Sep; 125(3):349-350. PubMed ID: 32505720
[No Abstract] [Full Text] [Related]
12. Cell-Free Therapies: Novel Approaches for COVID-19.
Maron-Gutierrez T; Rocco PRM
Front Immunol; 2020; 11():583017. PubMed ID: 33072130
[No Abstract] [Full Text] [Related]
13. The Ethics of COVID-19 Immunity-Based Licenses ("Immunity Passports").
Persad G; Emanuel EJ
JAMA; 2020 Jun; 323(22):2241-2242. PubMed ID: 32374357
[No Abstract] [Full Text] [Related]
14. Obesity, COVID-19 and immunotherapy: the complex relationship!
Finelli C
Immunotherapy; 2020 Oct; 12(15):1105-1109. PubMed ID: 32677493
[No Abstract] [Full Text] [Related]
15. SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection.
Altmann DM; Boyton RJ
Sci Immunol; 2020 Jul; 5(49):. PubMed ID: 32680954
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2: a new aetiology for atypical lymphocytes.
Gérard D; Henry S; Thomas B
Br J Haematol; 2020 Jun; 189(5):845. PubMed ID: 32311762
[No Abstract] [Full Text] [Related]
17. Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals.
Zhang F; Gan R; Zhen Z; Hu X; Li X; Zhou F; Liu Y; Chen C; Xie S; Zhang B; Wu X; Huang Z
Signal Transduct Target Ther; 2020 Aug; 5(1):156. PubMed ID: 32796814
[TBL] [Abstract][Full Text] [Related]
18. T cells found in coronavirus patients 'bode well' for long-term immunity.
Leslie M
Science; 2020 May; 368(6493):809-810. PubMed ID: 32439770
[No Abstract] [Full Text] [Related]
19. Reactive lymphocytes in patients with COVID-19.
Chong VCL; Lim KGE; Fan BE; Chan SSW; Ong KH; Kuperan P
Br J Haematol; 2020 Jun; 189(5):844. PubMed ID: 32297330
[No Abstract] [Full Text] [Related]
20. Immune asynchrony in COVID-19 pathogenesis and potential immunotherapies.
Zhou T; Su TT; Mudianto T; Wang J
J Exp Med; 2020 Oct; 217(10):. PubMed ID: 32910820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
